非那西丁

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 安全信息
  • 毒理性
  • MSDS
  • 结构与计算化学
  • 上游产品
  • 下游产品
  • 表征图谱

非那西丁 基本信息

中文名称:
非那西丁 
中文别名:
非那西丁;
菲那西汀;
非那西汀 
英文名称:
Acetamide,N-(4-ethoxyphenyl)-
英文别名:
phenacetin;
Acetphenetidin;
Phenacetin;
Contradouleur;
Acetophenetin;
N-(4-ethoxyphenyl)acetamide;
Acetophenetidine;
Achrocidin;
p-ethoxyacetanilide;
p-Acetophenetidide;
Acetophenetidin;
Codempiral;
4'-ethoxyacetanilide 
CAS No.:
62-44-2
分 子 式:

C10H13NO2

分 子 量:
179.22
精确分子量:
179.09500
PSA:
38.33000
MDL:
MFCD00009094
EINECS:
200-533-0
BRN:
1869238
InChI:
InChI=1/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)
危险品标志:

风险术语:

R22;R45   

安全术语:

S45;S53

分子结构式:
SDS:
查看

非那西丁 制备方法及用途

制备方法

(1)由对氨基苯乙醚经乙酰化而得。将苯、乙酐和对氨基苯乙醚的混合物,在油浴上加热共沸4h,反应完毕后冷却反应物,即析出非那汀,经过滤,冷苯洗涤,干燥即得,产量为理论量的86%。 (2)由乙酰氨基苯酚与乙醇钠作用而得:先将对乙酰胺基苯酚加于乙醇钠中,再缓缓加入碘乙烷,加热回流1h,冷却,过滤,所得粗品溶于乙醇中,过滤,滤液用热水稀释,再经冷却,过滤,干燥,而得成品,产量为理论量的80%。第一个方法也可不用苯作溶剂,而用乙酸代替,工艺过程如下。将40%的稀乙酸加热至沸,投入对氨基苯乙醚,蒸去水,待温度升到150℃时加入冰醋酸,回流1h,继续蒸,待温度升至150℃以上,取样测定游离氨基苯乙醚,根据残余的氨基苯乙醚量加入乙酐,回流反应0.5h,检查终点,合格后减压,回收乙酸至氨基含量在0.046以下,含酸0.2%以下,将反应液压入热精制母液中,搅拌降温至40℃,过滤,得非那西汀粗品。精制,非那西汀粗品加沸水或精制母液,加热搅拌溶解,过滤,滤液用酸调节至pH=4.5-4.7,加入活性炭及硫代硫酸钠搅拌脱色,过滤,滤液冷却结晶,甩滤,气流干燥,得非那西汀。

合成制备方法

(1)由对氨基苯乙醚经乙酰化而得。将苯、乙酐和对氨基苯乙醚的混合物,在油浴上加热共沸4h,反应完毕后冷却反应物,即析出非那汀,经过滤,冷苯洗涤,干燥即得,产量为理论量的86%

(2)由乙酰氨基苯酚与乙醇钠作用而得:先将对乙酰胺基苯酚加于乙醇钠中,再缓缓加入碘乙烷,加热回流1h,冷却,过滤,所得粗品溶于乙醇中,过滤,滤液用热水稀释,再经冷却,过滤,干燥,而得成品,产量为理论量的80%。第一个方法也可不用苯作溶剂,而用乙酸代替,工艺过程如下。将40%的稀乙酸加热至沸,投入对氨基苯乙醚,蒸去水,待温度升到150时加入冰醋酸,回流1h,继续蒸,待温度升至150以上,取样测定游离氨基苯乙醚,根据残余的氨基苯乙醚量加入乙酐,回流反应0.5h,检查终点,合格后减压,回收乙酸至氨基含量在0.046以下,含酸0.2%以下,将反应液压入热精制母液中,搅拌降温至40,过滤,得非那西汀粗品。精制,非那西汀粗品加沸水或精制母液,加热搅拌溶解,过滤,滤液用酸调节至pH=4.5-4.7,加入活性炭及硫代硫酸钠搅拌脱色,过滤,滤液冷却结晶,甩滤,气流干燥,得非那西汀。

 

用途简介

解热镇痛药,用于治疗发热头痛,神经痛等.解热作用强于镇痛作用。药效强度与阿斯匹林相当,作用徐缓而持久,毒性较低。研究表明:本品及其代谢产物扑热息痛均有解热作用。因为用酶抑制剂使非那西丁不能转化为扑热息痛时,仍可表现出明显的解热作用。故给线品后出现的解热作用不仅仅由其活性产物扑热息痛所产生。非那西丁的轻度镇痛作用,一般能维持3-4小时;与水杨酸类合用的协同作用,使镇痛效果增强。临床上主要用于小动物的解热镇痛。本品也是APC片剂的组分之一。

用途

对乙酰氨基苯乙醚用作有机合成原料及药物中间体。

非那西丁 物化性质

外观与性状:
白色结晶粉末
密度:
1.099 g/cm3
熔点:
133-136 °C(lit.)
沸点:
132 °C / 4mmHg
闪点:
168.5°C
水溶解性:
0.076 g/100 mL
折射率:
1.505 (20ºC)
存储条件/存储方法:
库房通风低温干燥,与还原剂、食品添加剂分开存放
其它信息:

1.       性状:白色有光泽的鳞片状结晶或白色结晶性粉末。无臭,味微苦。

2.       密度(g/mL,25/4):不确定

3.       相对蒸汽密度(g/mL,空气=1):不确定

4.       熔点(ºC):133-136 (lit.)

5.       沸点(ºC,常压):不确定

6.       沸点(ºC, 4mmHg):132

7.       折射率:1.571

8.       闪点(ºC):不确定

9.       比旋光度(º):不确定

10.    自燃点或引燃温度(ºC):不确定

11.    蒸气压(kPa,25ºC):不确定

12.    饱和蒸气压(kPa,60ºC):不确定

13.    燃烧热(KJ/mol):不确定

14.    临界温度(ºC):不确定

15.    临界压力(KPa):不确定

16.    油水(辛醇/水)分配系数的对数值:不确定

17.    爆炸上限(%,V/V):不确定

18.    爆炸下限(%,V/V):不确定

19.    溶解性:难溶于水,微溶于乙醚,略溶于沸水,溶于乙醇和氯仿。溶于浓硫酸时不显颜色,向溶液中滴入硝酸后即呈橙黄色。

非那西丁 安全信息

海关代码:
2924291000
WGK_Germany:
3
德国有关水污染物质的分类清单
危险类别码:
R22;R45
安全说明:
S53-S45
RTECS号:
AM4375000
安全标志:
S45:出现意外或者感到不适,立刻到医生那里寻求帮助(最好带去产品容器标签)。
S53:避免暴露——使用前先阅读专门的说明。
危险标志:
T:Toxic

非那西丁 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
AM4375000
CHEMICAL NAME :
p-Acetophenetidide
CAS REGISTRY NUMBER :
62-44-2
BEILSTEIN REFERENCE NO. :
1869238
LAST UPDATED :
199709
DATA ITEMS CITED :
77
MOLECULAR FORMULA :
C10-H13-N-O2
MOLECULAR WEIGHT :
179.24
WISWESSER LINE NOTATION :
2OR DMV1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
74 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
634 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
866 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LC50 - Lethal concentration, 50 percent kill
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
33900 mg/m3
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
540 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1625 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
260 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
2500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
1870 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - respiratory depression
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - hamster
DOSE/DURATION :
1690 mg/kg
TOXIC EFFECTS :
Behavioral - ataxia Behavioral - coma Cardiac - pulse rate increase, without fall in BP
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
10 gm/kg/4W-I
TOXIC EFFECTS :
Blood - methemoglobinemia-carboxyhemoglobin Blood - changes in other cell count (unspecified) Blood - changes in erythrocyte (RBC) count
TYPE OF TEST :
TCLo - Lowest published toxic concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
190 mg/m3/4H/30D-I
TOXIC EFFECTS :
Behavioral - alteration of classical conditioning Liver - liver function tests impaired
TYPE OF TEST :
TCLo - Lowest published toxic concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
15 mg/m3/4H/17W-I
TOXIC EFFECTS :
Brain and Coverings - recordings from specific areas of CNS Kidney, Ureter, Bladder - proteinuria Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
16 gm/kg/43W-C
TOXIC EFFECTS :
Kidney, Ureter, Bladder - other changes in urine composition
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
5625 mg/kg/9W-I
TOXIC EFFECTS :
Blood - pigmented or nucleated red blood cells Blood - changes in erythrocyte (RBC) count Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
80 gm/kg/63Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
57 gm/kg/47Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human
DOSE/DURATION :
7300 mg/kg/Y-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
572 gm/kg/60W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Sense Organs and Special Senses (Olfaction) - tumors Kidney, Ureter, Bladder - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1008 gm/kg/96W-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors Kidney, Ureter, Bladder - Kidney tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
19200 mg/kg/24W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
484 gm/kg/96W-C
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
27 gm/kg/10Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
9450 mg/kg/45W-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
206 gm/kg/2Y-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Sense Organs and Special Senses (Ear) - effect, not otherwise specified Skin and Appendages - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human
DOSE/DURATION :
28 gm/kg/28Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
126 gm/kg/25Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
140 gm/kg/13Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
50336 mg/kg
SEX/DURATION :
male 17 week(s) pre-mating
TOXIC EFFECTS :
Reproductive - Fertility - male fertility index (e.g. # males impregnating females per # males exposed to fertile nonpregnant females)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
24 gm/kg
SEX/DURATION :
female 1-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
6 gm/kg
SEX/DURATION :
female 1-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
62920 mg/kg
SEX/DURATION :
male 22 week(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - testes, epididymis, sperm duct
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
57200 mg/kg
SEX/DURATION :
male 20 week(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
DNA damage
TYPE OF TEST :
DNA damage
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
DNA damage
TYPE OF TEST :
DNA inhibition
TYPE OF TEST :
Sister chromatid exchange

MUTATION DATA

TYPE OF TEST :
Sister chromatid exchange
TEST SYSTEM :
Rodent - hamster Lung
DOSE/DURATION :
100 mg/L
REFERENCE :
SHIGAZ Shigaku. Ondotology. (Nippon Shika Daigaku Shigakkai, 1-9-20 Fujimi, Chiyodaku, Tokyo 102, Japan) V.38- 1949- Volume(issue)/page/year: 70,924,1983 *** REVIEWS *** IARC Cancer Review:Animal Sufficient Evidence IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,310,1987 IARC Cancer Review:Human Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 24,135,1980 IARC Cancer Review:Group 2A IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,310,1987 TOXICOLOGY REVIEW JRPMAP Journal of Reproductive Medicine. (2 Jacklynn Ct., St. Louis, MO 63132) V.3- 1969- Volume(issue)/page/year: 12,27,1974 TOXICOLOGY REVIEW AUHPAI Australian Journal of Hospital Pharmacy. (B.R. Miller, POB 125, Heidelberg, Vic., Australia) V.1- 1971- Volume(issue)/page/year: 3(3),100,1973 TOXICOLOGY REVIEW LANCAO Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- Volume(issue)/page/year: 2,1233,1969 TOXICOLOGY REVIEW AJMEAZ American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- Volume(issue)/page/year: 38,409,1965 TOXICOLOGY REVIEW CANCAR Cancer (Philadelphia). (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1948- Volume(issue)/page/year: 33,743,1974 TOXICOLOGY REVIEW ADCSAJ Advances in Chemistry Series. (American Chemical Soc., Distribution Office Dept. 223, POB 57136, West End Stn., Washington, DC 20037) No.1- 1950- Volume(issue)/page/year: 13,271,1970 TOXICOLOGY REVIEW BLFSBY Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973- Volume(issue)/page/year: 24,253,1983 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-RUSSIA:STEL 0.5 mg/m3 JAN 1993 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 80478 No. of Facilities: 126 (estimated) No. of Industries: 2 No. of Occupations: 10 No. of Employees: 4186 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X4389 No. of Facilities: 9 (estimated) No. of Industries: 1 No. of Occupations: 2 No. of Employees: 869 (estimated) No. of Female Employees: 617 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 80478 No. of Facilities: 1271 (estimated) No. of Industries: 4 No. of Occupations: 12 No. of Employees: 18808 (estimated) No. of Female Employees: 15338 (estimated)

非那西丁 MSDS

    非那西丁      修改号码:6    

模块 1. 化学品
    产品名称:      Phenacetin    
    修改号码:      6    

模块 2. 危险性概述
  GHS分类
     物理性危害        未分类    
     健康危害
    急性毒性(经口)      第4级    
    生殖细胞敏感性      第2级    
    致癌性      1A类    
    生殖毒性(对哺乳影响或通过哺乳影响)        对哺乳影响或通过哺乳影响的追加分类    
    特异性靶器官毒性        中枢神经系统    
  - 单一接触 [第1级]
    特异性靶器官毒性      血液, 肾脏    
  - 单一接触 [第1级]
     环境危害        未分类    
  GHS标签元素
     图标或危害标志
     信号词        危险    
     危险描述        吞咽有害。    
    怀疑会造成遗传缺陷
    可能致癌
    可能对母乳喂养的孩子造成损害
    对器官引起损害: 中枢神经系统
    可能因延长或接触对器官产生损害: 血液 肾脏
     防范说明
    非那西丁      修改号码:6    

模块 2. 危险性概述
  [预防]        使用前获取特定手册。    
    处理前必须阅读并理解所有安全措施。
    切勿吸入。
  在怀孕/哺乳期间避免接触。
    使用本产品时切勿吃东西,喝水或吸烟。
    处理后要彻底清洗双手。
    使用个人所需的防护用具。
  [急救措施]      食入:若感不适,呼叫解毒中心/医生。漱口。    
  如接触到或相关接触:求医/就诊。
  [储存]        存放处须加锁。    
  [废弃处置]      根据当地政府规定把物品/容器交与工业废弃处理机构。    

模块 3. 成分/组成信息
  单一物质/混和物        单一物质    
  化学名(中文名):        非那西丁    
    百分比:      >99.0%(GC)    
  CAS编码:      62-44-2    
    俗名:      N-Acetyl-4-ethoxyaniline , N-Acetyl-p-phenetidine , 4'-Ethoxyacetanilide    
    分子式:      C10H13NO2    

模块 4. 急救措施
    吸入:      将受害者移到新鲜空气处,保持呼吸通畅,休息。求医/就诊。    
    皮肤接触:      立即去除/脱掉所有被污染的衣物。用大量肥皂和水轻轻洗。    
  求医/就诊。
    眼睛接触:        用水小心清洗几分钟。如果方便,易操作,摘除隐形眼镜。    
  求医/就诊。
    食入:      求医/就诊。漱口。    
    紧急救助者的防护:        救援者需要穿戴个人防护用品,比如橡胶手套和气密性护目镜。    

模块 5. 消防措施
    合适的灭火剂:        干粉,泡沫,雾状水,二氧化碳    
    特殊危险性:        小心,燃烧或高温下可能分解产生毒烟。    
    特定方法:        从上风处灭火,根据周围环境选择合适的灭火方法。    
    非相关人员应该撤离至安全地方。
    周围一旦着火:如果安全,移去可移动容器。
    消防员的特殊防护用具:        灭火时,一定要穿戴个人防护用品。    

模块 6. 泄漏应急处理
    个人防护措施,防护用具,      使用特殊的个人防护用品(针对有毒颗粒的P3过滤式空气呼吸器)。远离溢出物/泄露    
    紧急措施:        处并处在上风处。    
    泄露区应该用安全带等圈起来,控制非相关人员进入。
    环保措施:        防止进入下水道。    
    控制和清洗的方法和材料:        清扫收集粉尘,封入密闭容器。注意切勿分散。附着物或收集物应该立即根据合适的    
    法律法规处置。

模块 7. 操作处置与储存
    处理
    技术措施:        在通风良好处进行处理。穿戴合适的防护用具。防止粉尘扩散。处理后彻底清洗双手    
    和脸。
    非那西丁      修改号码:6    

模块 7. 操作处置与储存
    注意事项:        如果可能,使用封闭系统。如果粉尘或浮质产生,使用局部排气。    
    操作处置注意事项:        避免所有部位的接触!    
    贮存
    储存条件:        保持容器密闭。存放于凉爽、阴暗处。    
    存放处须加锁。
    远离不相容的材料比如氧化剂存放。
    包装材料:        依据法律。    

模块 8. 接触控制和个体防护
    工程控制:        尽可能安装封闭体系或局部排风系统。同时安装淋浴器和洗眼器。    
    个人防护用品
     呼吸系统防护:      防尘面具,自携式呼吸器(SCBA),供气呼吸器等。使用通过政府标准的呼吸器。依    
    据当地和政府法规。
     手部防护:        防渗手套。    
     眼睛防护:        护目镜。如果情况需要,佩戴面具。    
     皮肤和身体防护:        防渗防护服。如果情况需要,穿戴防护靴。    

模块 9. 理化特性
    固体
  外形(20°C):
    外观:      晶体-粉末    
    颜色:        白色类白色    
    气味:        无味    
  pH:        无数据资料    
    熔点:      136°C    
  沸点/沸程      132 °C/0.5kPa    
    闪点:        无资料    
    爆炸特性
     爆炸下限:        无资料    
     爆炸上限:        无资料    
    蒸气压:      0.4kPa/25°C    
    密度:        无资料    
    溶解度:
  [水]
  不溶于(530mg/L, 25°C)
  [其他溶剂]
    易溶于:        嘧啶    
    溶于:      丙酮, 氯仿, 甘油    
    微溶于:      醚, 苯    
  log水分配系数 =      1.58    

模块 10. 稳定性和反应性
    化学稳定性:        一般情况下稳定。    
    危险反应的可能性:        未报道特殊反应性。    
    须避免接触的物质      氧化剂, 强酸, 强碱, 还原剂    
  危险的分解产物:      一氧化碳, 二氧化碳, 氮氧化物 (NOx)    

模块 11. 毒理学信息
    急性毒性:      orl-rat LD50:1650 mg/kg    
  ihl-mus LC50:33900 mg/m3
  ipr-rat LD50:634 mg/kg
    非那西丁      修改号码:6    

模块 11. 毒理学信息
    对皮肤腐蚀或刺激:        无资料    
    对眼睛严重损害或刺激:        无资料    
    生殖细胞变异原性:      dnd-hmn-oth 1 mmol/L/20H    
  mmo-hmn-lym 1500 mg/L (+S9)
  mmo-sat 333 ug/plate (-S9)
  sce-mus-ipr 165 mg/kg
    致癌性:      orl-hmn TDLo:7300 mg/1Y-C    
  orl-man TDLo:57 g/kg/47Y-I
  orl-rat TDLo:572 g/kg/60W-C
  orl-wmn TDLo:80 g/kg/63Y-I
  IARC =      1 (对人类致癌)。    
  NTP =      a(已知致癌物)。    
    生殖毒性:        无资料    
  RTECS 号码:      AM4375000    

模块 12. 生态学信息
    生态毒性:
    鱼类:      48h LC50:335 ppm (Oryzias latipes)    
    甲壳类:        无资料    
    藻类:        无资料    
  残留性 / 降解性:      8.4 % (by BOD), 22.8 % (by TOC)    
  潜在生物累积 (BCF):      <3 (conc. 0.3 ppm), <30 (conc. 0.03 ppm)    
    土壤中移动性
   log水分配系数:      1.58    
   土壤吸收系数 (Koc):      170    
     亨利定律      2.16 x 10-5    
  constant(PaM3/mol):

模块 13. 废弃处置
    如果可能,回收处理。请咨询当地管理部门。建议在可燃溶剂中溶解混合,在装有后燃和洗涤装置的化学焚烧炉中
    焚烧。废弃处置时请遵守国家、地区和当地的所有法规。

模块 14. 运输信息
    联合国分类:        与联合国分类标准不一致    
  UN编号:        未列明    

模块 15. 法规信息
  《危险化学品安全管理条例》(2002年1月26日国务院发布,2011年2月16日修订): 针对危险化学品的安全使用、
    生产、储存、运输、装卸等方面均作了相应的规定。
    非那西丁      修改号码:6    


模块16 - 其他信息
N/A

非那西丁 分子结构与计算化学数据

分子结构数据

五、分子性质数据:

1、   摩尔折射率:51.83

2、   摩尔体积(m3/mol):163.0

3、   等张比容(90.2K):407.4

4、   表面张力(dyne/cm):39.0

5、   极化率10-24cm3):20.54

计算化学数据

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:1

3.氢键受体数量:2

4.可旋转化学键数量:3

5.互变异构体数量:3

6.拓扑分子极性表面积38.3

7.重原子数量:13

8.表面电荷:0

9.复杂度:162

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

推荐供应商更多供应商>>

北京百灵威科技有限公司

产品介绍:
产品名称:乙酰对氨基苯乙醚 179536 Cas号:62-44-2 纯度:99%,是非阿片类镇痛化合物,能够抑制 COX-3 的活性,具有抗炎活性 包装信息:50g,250g,1kg 价格:洽谈
联系方式:
联系人:翟先生 电话:18210857532 手机:18210857532